Skip to content
+44 (0)203 764 9530 avillion@avillionllp.com Contact

Avillion

  • Partnerships
  • An Innovative Model
  • The Team
  • Business Opportunity
  • Our Investors
  • News

News

Latest News

11Jan
2023

Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma

31May
2022

US FDA accepts New Drug Application filed by Avillion for AstraZeneca’s PT027 for the as-needed treatment or prevention of symptoms in asthma patients

16May
2022

Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca’s PT027 in asthma patients in the New England Journal of Medicine

09Sep
2021

Avillion announces positive results in MANDALA and DENALI Phase III trials of AstraZeneca’s PT027, a fixed-dose combination of albuterol and budesonide, demonstrating significant benefits for asthma patients

10May
2021

JPM ranked Avillion #61 in the top 200 Female-Powered Private Businesses in the UK – April 2021

23Apr
2021

Avillion’s positive Phase 2 trial of tri-specific Nanobody® sonelokimab (M1095) in chronic psoriasis published in The Lancet

01Apr
2021

OxSonics Appoints Dr Allison Jeynes as Chair of the Board

29Oct
2020

Positive results from Avillion’s Phase 2 trial of sonelokimab (M1095) in chronic psoriasis to be presented today in Late-Breaking News Session at EADV 2020 Virtual

1 2 3 4 Next

Categories

  • Deals
  • Delivered & milestones achieved
  • Other
  • People
  • Uncategorized

News Archive

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Avillion

  • Partnerships
  • Governance
  • Areas of interest
  • An Innovative Model
  • Operational Excellence
  • Study Delivery
  • Case Study
  • Business Opportunity
  • What we do
  • Global outreach
  • Frequently Asked Questions

Contact

+44 (0)203 764 9530 avillion@avillionllp.com Linkedin

© Avillion LLP. Registered in England and Wales No: OC379058

Privacy Policy | Cookie Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cookie Overview

Cookies are small text files that are placed on your device when you visit a website. Cookies may be used to keep track of pages visited within the site, help you continue where you left off or remember your preferences, such as language settings.
Cookies help us to make online services easier to use, monitor the use of our site and help us improve the service provided to you.

TYPES OF COOKIES
Cookies can be “persistent” or “session” cookies. Persistent cookies remain on your device for a period of time when you go offline, while session cookies are deleted as soon as you close your web browser.

COOKIE PREFERECNES
You may change your preferences at any time or withdraw your consent for each cookie category - except Required cookies using this website’s cookie setting option.

Required Cookies

Required cookies (persistent) should be enabled at all times so that we can save your cookie preferences.

These cookies are essential to enable you to move around the website and use its features.

Operational Cookies

These cookies (which can be persistent or session) collect information about how visitors use a website, for instance which pages visitors go to most often and if they receive error messages. They are used to improve how a website works in future versions, e.g. Google Analytics, Microsoft Clarity.

Please enable required cookies first so that we can save your preferences!

Privacy Policy

More information about our Privacy Policy